Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Cell Tissue Research
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Distributed through LillyDirect 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read 5-Amino-1MQ Peptide: Benefits, Uses, Side Effects, Dosage, and Research
These supplements do not replace BPC-157 but support its effects
